Go to deals
Private Equity | Healthcare

Gilde Healthcare has invested in Tandarts Today

Gilde Healthcare has invested in Tandarts Today, a fast-growing dental chain in the Netherlands. The investment will allow Tandarts Today to accelerate its buy-and-build strategy and become a leading dental chain in the Netherlands. Financial details have not been disclosed.

Tandarts Today, founded in 2015, offers all disciplines of regular dentistry, including special treatments such as implantology, orthodontics, periodontology and aesthetic treatments. Furthermore, through its own dental laboratories, it develops hockey bits, custom-made prostheses, bridges and other dental work pieces.

Gilde Healthcare is a specialized European healthcare investor managing over US$1.5 billion across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in health tech and therapeutics. The venture & growth companies are based in Europe and North America. Gilde Healthcare’s private equity fund invests in profitable European lower mid-market healthcare companies, with a focus on the Benelux and DACH regions. The private equity fund targets healthcare, suppliers of medical products and service providers in the healthcare market.

Oaklins’ team in the Netherlands acted as the exclusive financial advisor to the seller in this transaction.

Service
M&A sell-side
Parties
“I am delighted to welcome Gilde Healthcare as a shareholder in Tandarts Today. Their experience in buy-and-build strategies combined with their healthcare angle and focus makes Gilde Healthcare the perfect partner to realize Tandarts Today’s growth objectives. Oaklins played a fundamental role in identifying Gilde Healthcare as a buyer and realizing the transaction in a dedicated and professional manner.”

Ruben Hoefnagels

Founder and CEO, Tandarts Today

Talk to the deal team

 Adse  de Kock

Adse de Kock

Partner
Amsterdam, Netherlands
Oaklins Netherlands
 Oscar  van Leeuwen

Oscar van Leeuwen

Director
Amsterdam, Netherlands
Oaklins Netherlands
 Sander  van 't Spijker

Sander van 't Spijker

Senior Associate
Amsterdam, Netherlands
Oaklins Netherlands
 Friso  Kuiters

Friso Kuiters

Associate
Amsterdam, Netherlands
Oaklins Netherlands

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
PSG Equity has made a strategic growth investment in Rodeo Software
Private Equity | TMT

PSG Equity has made a strategic growth investment in Rodeo Software

PSG Equity has made a strategic growth investment in Rodeo Software B.V., the leading project management SaaS platform, to accelerate its growth through increased GTM investment and geographical expansion.

Learn more
Agar Scientific has been acquired by Calibre Scientific
Private Equity | Healthcare

Agar Scientific has been acquired by Calibre Scientific

Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.

Learn more